Doubrovinskaja S, Korporal-Kuhnke M, Jarius S, Haas J, et al. Newly emerging type B insulin resistance (TBIR) during treatment with eculizumab for AQP4-IgG-positive neuromyelitis optica spectrum disorder (NMOSD): fatal outcome. J Neurol 2024;271:2866-2870.
PMID: 37962590